best mid cap performing stocks january

Immunitybio (IBRX) had the highest return in January 2026 by a mid-cap US stock, returning 209.4%.

ASSETMONTH% RETURN
Immunitybio (IBRX)
January 2026
209.41%
Erasca (ERAS)
January 2026
183.29%
Alumis (ALMS)
January 2026
150.87%
USA Rare Earth (USAR)
January 2026
82.57%
Enliven Therapeutics (ELVN)
January 2026
70.65%
Ultra Clean (UCTT)
January 2026
67.1%
Ichor (ICHR)
January 2026
58.1%
Energy Fuels (UUUU)
January 2026
53.07%
Hycroft Mining (HYMC)
January 2026
52.29%
Fluence Energy (FLNC)
January 2026
51.13%
Neogen (NEOG)
January 2026
47.47%
Amprius Technologies (AMPX)
January 2026
47.22%
Denison Mines (DNN)
January 2026
44.53%
Uranium Energy (UEC)
January 2026
44.27%
Telephone and Data Systems (TDS)
January 2026
42.09%
Acm Research (ACMR)
January 2026
41.76%
Nexa Resources (NEXA)
January 2026
40.11%
Brookdale Senior Living (BKD)
January 2026
39.93%
Karman (KRMN)
January 2026
39.84%
Astronics (ATRO)
January 2026
39.22%
Allegro Microsystems  (ALGM)
January 2026
36.7%
Figure Technology Solutions, Inc Class A Common Stock (FIGR)
January 2026
36.27%
Vishay Intertechnology (VSH)
January 2026
35.87%
Plexus (PLXS)
January 2026
35.39%
Frontline (FRO)
January 2026
34.75%
Mid-cap stocks are treated as having a market cap between $2B and $10B.